What This Instrument Does
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (May Update) Instrument 2026 is a technical update to the rules around how chemotherapy drugs are funded under the Pharmaceutical Benefits Scheme. It was made by the Department of Health, Disability and Ageing under the National Health Act 1953.
The instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
Timing
The instrument took effect on 30 April 2026. It was in force until 18 August 2026, when it was repealed and replaced by a later update.
Scope of Changes
The source text does not specify the detailed changes made to drug listings, dosages, or funding amounts.
Relevance
This instrument relates to PBS administration and is not something most small businesses need to act on, though it may be relevant to pharmacies or healthcare providers dispensing chemotherapy medicines.
Key Actions
- Pharmacies and healthcare providers involved in dispensing chemotherapy drugs can check the current version of the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 at the Federal Register of Legislation to confirm which rules currently apply, since this version has already been repealed and replaced.
- For specific schedule changes, the full legislative text and explanatory statement are available on the Federal Register of Legislation page for this instrument.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.